Cargando…
Ryanodine receptors are targeted by anti-apoptotic Bcl-X(L) involving its BH4 domain and Lys87 from its BH3 domain
Anti-apoptotic B-cell lymphoma 2 (Bcl-2) family members target several intracellular Ca(2+)-transport systems. Bcl-2, via its N-terminal Bcl-2 homology (BH) 4 domain, inhibits both inositol 1,4,5-trisphosphate receptors (IP(3)Rs) and ryanodine receptors (RyRs), while Bcl-X(L), likely independently o...
Autores principales: | Vervliet, Tim, Lemmens, Irma, Vandermarliere, Elien, Decrock, Elke, Ivanova, Hristina, Monaco, Giovanni, Sorrentino, Vincenzo, Kasri, Nael Nadif, Missiaen, Ludwig, Martens, Lennart, De Smedt, Humbert, Leybaert, Luc, Parys, Jan B., Tavernier, Jan, Bultynck, Geert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397538/ https://www.ncbi.nlm.nih.gov/pubmed/25872771 http://dx.doi.org/10.1038/srep09641 |
Ejemplares similares
-
Selective regulation of IP(3)-receptor-mediated Ca(2+) signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl
por: Monaco, G, et al.
Publicado: (2012) -
Alpha-Helical Destabilization of the Bcl-2-BH4-Domain Peptide Abolishes Its Ability to Inhibit the IP(3) Receptor
por: Monaco, Giovanni, et al.
Publicado: (2013) -
IP(3)R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP(3)R-derived peptide targeting the BH4 domain of Bcl-2
por: Akl, H, et al.
Publicado: (2013) -
Antagonizing Bcl-2′s BH4 domain in cancer
por: Vervloessem, Tamara, et al.
Publicado: (2015) -
BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis
por: Vervliet, Tim, et al.
Publicado: (2018)